Neumora Therapeutics (NASDAQ:NMRA) Lowered to “Neutral” Rating by Guggenheim
Guggenheim lowered shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) from a buy rating to a neutral rating in a research note released on Friday morning, Marketbeat.com reports. Other analysts have also issued research reports about the stock. HC Wainwright lowered their price objective on shares of Neumora Therapeutics from $30.00 to $18.00 and set […]
Guggenheim lowered shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) from a buy rating to a neutral rating in a research note released on Friday morning, Marketbeat.com reports. Other analysts have also issued research reports about the stock. HC Wainwright lowered their price objective on shares of Neumora Therapeutics from $30.00 to $18.00 and set […]
